Browsing Category

45633 posts

A Pivotal Phase II/III Clinical Study of Anti-HER2 Bispecific Antibody KN026 Have Met the Primary Endpoint of PFS at Interim Analysis

SUZHOU, China, May 1, 2025 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK)…

Canadian Solar Files Annual Report on Form 20-F for Year Ended December 31, 2024

KITCHENER, ON, May 1, 2025 /PRNewswire/ — Canadian Solar Inc. (the "Company",…
U.S. Immigration Fund Welcomes Benny Chang as Director of Business Development, Taiwan

U.S. Immigration Fund Welcomes Benny Chang as Director of Business Development, Taiwan

PALM BEACH, Fla., May 1, 2025 /PRNewswire/ — U.S. Immigration Fund (USIF),…
U.S. Immigration Fund Welcomes Emily Zhu as Vice President of Business Development, Head of East Asia

U.S. Immigration Fund Welcomes Emily Zhu as Vice President of Business Development, Head of East Asia

PALM BEACH, Fla., May 1, 2025 /PRNewswire/ — U.S. Immigration Fund (USIF),…
LG Display Becomes World's First to Verify Commercialization of Blue Phosphorescent OLED Panels

LG Display Becomes World's First to Verify Commercialization of Blue Phosphorescent OLED Panels

Final Step to Achieving "Dream OLED" SEOUL, South Korea, May 1, 2025…

Preserving fertility and optimising care for the one in seven women suffering from endometriosis

SINGAPORE, May 1, 2025 /PRNewswire/ — Fertility specialists in the Asia Pacific region…

Rediscovering Quality Home Life Through Nature-Inspired Design at 137th Canton Fair

GUANGZHOU, China, May 1, 2025 /PRNewswire/ — In the fast-paced rhythm of…
S&E bio Receives Korea's First Approval for Exosome-Based Therapy Clinical Trial

S&E bio Receives Korea's First Approval for Exosome-Based Therapy Clinical Trial

SEOUL, South Korea, May 1, 2025 /PRNewswire/ — S&E bio Co., Ltd.,…